APIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.121000E-01
Normal-vs-Stage2
6.697000E-01
Normal-vs-Stage3
4.417000E-01
Normal-vs-Stage4
6.414800E-01
Stage1-vs-Stage2
2.443200E-01
Stage1-vs-Stage3
1.530240E-01
Stage1-vs-Stage4
3.260000E-01
Stage2-vs-Stage3
2.097600E-01
Stage2-vs-Stage4
9.655200E-01
Stage3-vs-Stage4
2.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.898200E-01
Normal-vs-AfricanAmerican
7.243400E-01
Normal-vs-Asian
8.846400E-01
Caucasian-vs-AfricanAmerican
7.303800E-01
Caucasian-vs-Asian
4.426400E-01
AfricanAmerican-vs-Asian
8.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.617400E-01
Normal-vs-Female
6.647400E-01
Male-vs-Female
6.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.503200E-01
Normal-vs-Age(41-60Yrs)
3.283400E-01
Normal-vs-Age(61-80Yrs)
7.147000E-01
Normal-vs-Age(81-100Yrs)
8.018000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.772200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.652000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.420600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.296500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.347200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.244800E-01
Normal-vs-Daily Drinker
8.200600E-01
Normal-vs-Weekly Drinker
9.993600E-01
Normal-vs-Occasional Drinker
3.551400E-01
Normal-vs-Social Drinker
6.256800E-01
Non Drinker-vs-Daily Drinker
6.879200E-01
Non Drinker-vs-Weekly Drinker
5.382600E-01
Non Drinker-vs-Occasional Drinker
1.668250E-01
Non Drinker-vs-Social Drinker
8.638200E-01
Daily Drinker-vs-Weekly Drinker
7.384000E-01
Daily Drinker-vs-Occasional Drinker
8.094400E-02
Daily Drinker-vs-Social Drinker
7.876000E-01
Weekly Drinker-vs-Occasional Drinker
1.174800E-01
Weekly Drinker-vs-Social Drinker
6.163800E-01
Occasional Drinker-vs-Social Drinker
1.285570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.261200E-01
Normal-vs-Grade 2
1.779750E-01
Normal-vs-Grade 3
6.591000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.558000E-01
Grade 1-vs-Grade 3
3.225000E-01
Grade 1-vs-Grade 4
2.261200E-01
Grade 2-vs-Grade 3
6.020000E-01
Grade 2-vs-Grade 4
1.779750E-01
Grade 3-vs-Grade 4
6.591000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.651200E-01
Normal-vs-NonDiabetic
6.425200E-01
Diabetic-vs-NonDiabetic
6.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.268800E-01
Normal-vs-NoPancreatitis
6.745600E-01
Pancreatitis-vs-NoPancreatitis
8.206000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.204400E-01
Normal-vs-N1
7.099200E-01
N0-vs-N1
3.694000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.943200E-01
Normal-vs-TP53-NonMutant
6.241600E-02
TP53-Mutant-vs-TP53-NonMutant
3.215400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
